Loading the state's markets…
Loading the state's markets…
Loading the market…
Medicare market size, surgeons and outlook to 2030
Medicare fee-for-service EP ablation cases in Wisconsin: reported (2020, the pandemic year, left out of the line), then forecast with its 80% range. One year ahead, this procedure’s market forecast has been off by 4% on average (230 state-years, 2020–2024): a close guide.
| Year | Surgeons | Medicare FFS | Advantage share |
|---|---|---|---|
| 2019 | 28 | 1,135 | 47% |
| 2020 | 30 | 1,164 | 49% |
| 2021 | 38 | 1,445 | 53% |
| 2022 | 35 | 1,445 | 56% |
| 2023 | 37 | 1,531 | 59% |
| 2024 | 48 | 1,918 | 61% |
| 2025 from claims | – | 2,277 2,089–2,409 | 61% |
| 2026 forecast | – | 2,550 2,244–2,943 | 61% |
| 2027 forecast | – | 2,797 2,392–3,334 | 61% |
| 2028 forecast | – | 3,068 2,560–3,757 | 61% |
| 2029 forecast | – | 3,365 2,748–4,220 | 62% |
| 2030 forecast | – | 3,690 2,956–4,729 | 62% |
AF, SVT, and VT catheter ablation. Professional codes (what the surgeon bills): CPT 93656, 93653, 93654; the hospital bills MS-DRG 273, 274, 317.
Surgeons and fee-for-service cases are from CMS’s Medicare Physician & Other Practitioners files, counted where the surgeon billed; state totals include the cases CMS leaves out of the surgeon-level file (under 11 patients). All Medicare adds patients in Medicare Advantage at the state’s enrollment share; all payers scales Medicare by its share of the procedure nationally. The forecast carries cases per resident 65+ forward with the Census projection of residents 65+. How the numbers are made · Data sources
The 10 busiest do 41% of the cases CMS names in Wisconsin; 29 surgeons do 80% of them.
MedaRep names every one, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
In 2025, 8% inpatient hospital, 92% hospital outpatient.
CMS rule changes ahead
From CMS’s OPPS/ASC final rules; the move measured on CMS’s claim summary, nationally, code by code. Medicare only, and not in the projected bars.
| State | Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast |
|---|---|---|---|---|---|---|
| Illinois | 109 | 5,700+7.4%/yr | +7.4%/yr | 3.6 | 0% | 10,500 in 2030+11%/yr |
| Ohio | 100 | 4,592+3.6%/yr | +3.6%/yr | 3.4 | 0% | 7,400 in 2030+8.3%/yr |
| Indiana | 62 | 3,095+8.8%/yr | +8.8%/yr | 3.7 | 0% | 5,760 in 2030+11%/yr |
| Michigan | 66 | 2,682+0.7%/yr | +0.7%/yr | 2.6 | 0% | 4,190 in 2030+7.7%/yr |
| Minnesota | 48 | 1,991+7%/yr | +7%/yr | 3.6 | 0% | 4,870 in 2030+16%/yr |
| Missouri | 37 | 1,982+3.6%/yr | +3.6%/yr | 2.7 | 0% | 3,810 in 2030+11%/yr |
| Kansas | 27 | 1,645+7.2%/yr | +7.2%/yr | 3.6 | 0% | 2,880 in 2030+9.8%/yr |
| Iowa | 27 | 1,505+14%/yr | +14%/yr | 3.0 | 0% | 2,760 in 2030+11%/yr |
| Nebraska | 15 | 802+7.1%/yr | +7.1%/yr | 2.8 | 0% | 1,560 in 2030+12%/yr |
| South Dakota | 5 | 296+14%/yr | +14%/yr | 2.0 | 0% | 610 in 2030+13%/yr |
| North Dakota | 5 | 223+7.5%/yr | +7.5%/yr | 2.0 | 0% | 500 in 2030+15%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Pacemaker, ICD & CRT implantation | 51 | 2,533−2.6%/yr | −2.6%/yr | 4.70.9× | 0% | 2,880 in 2030+2.1%/yr |
| LAA occlusion & loop recorders | 50 | 1,796+14%/yr | +14%/yr | 2.70.9× | 0% | 3,250 in 2030+10%/yr |
EP ablation in every state, and its device makers · Every procedure market in Wisconsin · Every state · Compare with Illinois
Johnson & Johnson MedTech leads with 36% of company spending on these surgeons in 2025, −28 pts on 2024.
In 2025, 7 companies reported engagement with Wisconsin’s surgeons worth $152K in consulting, speaking, meals and travel tied to these products, about $3,172 per surgeon billing it. Royalties are left out.
FDA, last 12 months: 102 clearances and approvals in the category, 5 recalled product lines. A recall is a public FDA notice, not a finding of fault.
Which surgeons each company engages, and the dollars reported, are in the ranking. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing. Every company in the category.
Share of the cases CMS names by surgeon, by where they billed. Open one for its ranking.